Abner Herrman & Brock’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$355K Hold
14,750
0.03% 83
2026
Q1
$414K Sell
14,750
-249
-2% -$6.63K 0.05% 74
2025
Q4
$373K Buy
14,999
+249
+2% +$6.28K 0.04% 86
2025
Q3
$376K Hold
14,750
0.04% 85
2025
Q2
$358K Hold
14,750
0.04% 53
2025
Q1
$374K Hold
14,750
0.05% 51
2024
Q4
$391K Buy
14,750
+1,000
+7% +$27.1K 0.05% 52
2024
Q3
$398K Sell
13,750
-200
-1% -$5.83K 0.05% 71
2024
Q2
$390K Hold
13,950
0.05% 69
2024
Q1
$387K Buy
13,950
+1,136
+9% +$31.5K 0.05% 66
2023
Q4
$369K Buy
12,814
+1,225
+11% +$37K 0.05% 72
2023
Q3
$384K Sell
11,589
-365
-3% -$12.9K 0.06% 69
2023
Q2
$438K Buy
11,954
+141
+1% +$5.49K 0.06% 68
2023
Q1
$482K Hold
11,813
0.07% 69
2022
Q4
$605K Hold
11,813
0.09% 57
2022
Q3
$517K Hold
11,813
0.09% 56
2022
Q2
$619K Buy
11,813
+2,546
+27% +$130K 0.11% 55
2022
Q1
$480K Sell
9,267
-204
-2% -$10.6K 0.07% 67
2021
Q4
$559K Buy
9,471
+924
+11% +$45.8K 0.07% 68
2021
Q3
$368K Sell
8,547
-103
-1% -$4.56K 0.05% 73
2021
Q2
$339K Sell
8,650
-38,425
-82% -$1.49M 0.05% 72
2021
Q1
$1.71M Sell
47,075
-53,787
-53% -$1.91M 0.26% 50
2020
Q4
$3.71M Sell
100,862
-5,835
-5% -$214K 0.58% 43
2020
Q3
$3.71M Sell
106,697
-75,212
-41% -$2.64M 0.63% 44
2020
Q2
$5.64M Buy
181,909
+118,449
+187% +$4.02M 1.01% 35
2020
Q1
$1.97M Buy
63,460
+34,845
+122% +$1.19M 0.45% 42
2019
Q4
$1.06M Buy
28,615
+790
+3% +$28.1K 0.16% 60
2019
Q3
$949K Sell
27,825
-1,051
-4% -$38.2K 0.14% 61
2019
Q2
$1.19M Sell
28,876
-1,112
-4% -$44.2K 0.17% 57
2019
Q1
$1.21M Sell
29,988
-149
-0.5% -$5.97K 0.19% 56
2018
Q4
$1.25M Buy
30,137
+5,225
+21% +$217K 0.23% 50
2018
Q3
$1.04M Buy
24,912
+705
+3% +$27.1K 0.15% 68
2018
Q2
$833K Buy
24,207
+1,108
+5% +$37.9K 0.13% 72
2018
Q1
$778K Buy
23,099
+106
+0.5% +$3.64K 0.12% 75
2017
Q4
$790K Buy
22,993
+5
+0% +$170 0.13% 76
2017
Q3
$779K Buy
22,988
+2,918
+15% +$93.8K 0.14% 77
2017
Q2
$640K Buy
20,070
+608
+3% +$19.2K 0.12% 81
2017
Q1
$632K Buy
19,462
+2,640
+16% +$83.2K 0.13% 73
2016
Q4
$536K Sell
16,822
-417,738
-96% -$12.8M 0.11% 75
2016
Q3
$14M Buy
434,560
+16,052
+4% +$537K 3.17% 3
2016
Q2
$14.4M Buy
418,508
+5,354
+1% +$171K 3.34% 3
2016
Q1
$11.6M Buy
413,154
+103,344
+33% +$2.95M 2.92% 5
2015
Q4
$9.49M Buy
309,810
+14,187
+5% +$446K 4.89% 3
2015
Q3
$9.34M Buy
295,623
+11,462
+4% +$368K 4.98% 2
2015
Q2
$9.13M Buy
284,161
+10,160
+4% +$331K 4.58% 3
2015
Q1
$9.04M Sell
274,001
-3,151
-1% -$100K 4.6% 4
2014
Q4
$8.19M Buy
277,152
+229,543
+482% +$6.58M 4.15% 2
2014
Q3
$1.34M Buy
47,609
+17,839
+60% +$501K 0.39% 57
2014
Q2
$838K Hold
29,770
0.25% 59
2014
Q1
$907K Buy
29,770
+9,287
+45% +$277K 0.29% 59
2013
Q4
$594K Buy
20,483
+3,675
+22% +$107K 0.21% 65
2013
Q3
$458K Sell
16,808
-3,777
-18% -$103K 0.3% 66
2013
Q2
$547K Buy
+20,585
New +$569K 0.23% 68

Other funds holding PFE

Abner Herrman & Brock's PFE Position: Q2 2026 in Review

Abner Herrman & Brock held its Pfizer (PFE) position steady in Q2 2026 at 14,750 shares worth $355K. The position accounts for 0.03% of the portfolio, ranked #83.

Abner Herrman & Brock first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.4M in Q2 2016. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Abner Herrman & Brock held 14,750 shares of Pfizer worth $355K as of Q2 2026.
  • Abner Herrman & Brock left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.03% of Abner Herrman & Brock's portfolio in Q2 2026, its #83 holding.
  • Abner Herrman & Brock first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Abner Herrman & Brock's Pfizer position peaked at $14.4M in Q2 2016.
  • 491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Abner Herrman & Brock's 13F filing for Q2 2026, filed 8 Jul 2026.